Art

J-GLOBAL ID：201502215933606127   Reference number：15A1025320

Cabergoline administration prevents development of moderate to severe ovarian hyperstimulation syndrome and it contributes to reduction in ovarian volume

カベルゴリン投与は中等度から重度の卵巣過刺激症候群の発生を予防し卵巣容積の減少に寄与する

Author (6)： INOUE Tomoko (IVF Namba Clinic, 1-17-28 Minamihorie, Nishi-ku, 550-0015, Osaka, JPN) ,  HASHIMOTO Shu (IVF Namba Clinic, 1-17-28 Minamihorie, Nishi-ku, 550-0015, Osaka, JPN) ,  IWAHATA Hideyuki (IVF Namba Clinic, 1-17-28 Minamihorie, Nishi-ku, 550-0015, Osaka, JPN) ,  ITO Keijiro (IVF Namba Clinic, 1-17-28 Minamihorie, Nishi-ku, 550-0015, Osaka, JPN) ,  NAKAOKA Yoshiharu (IVF Namba Clinic, 1-17-28 Minamihorie, Nishi-ku, 550-0015, Osaka, JPN) ,  MORIMOTO Yoshiharu (IVF Namba Clinic, 1-17-28 Minamihorie, Nishi-ku, 550-0015, Osaka, JPN)
Material： Reproductive Medicine and Biology  (Reprod Med Biol)
Volume： 14  Issue： 2  Page： 79-84  Publication year： Apr. 2015 
JST Material Number： L7364A  ISSN： 1445-5781  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： *dopaminergic drug ,...
Semi thesaurus term： *Ovarian Hyperstimulation Syndrome ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A1025320&from=J-GLOBAL&jstjournalNo=L7364A") }}

JST classification (3)： Clinical application of other drugs acting on central nervous system  (GW03130F) ,  Clinical application of drugs acting on endocrine system and genital organ  (GW10020V) ,  Drug therapy(=pharmacotherapy)for gynecologic and obstetrical diseases  (GS05020N)

Substance index (4)： Ganirelix ,  Cabergoline ,  Cetrorelix acetate ,  Buserelin acetate

Reference (25)：

• The practice committee of the American society for reproductive medicine: ovarian hyperstimulation syndrome. Fertil Steril 2008;90:S188-93.
• Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril. 2000;74:429-38.
• Soares SR, Gómez R, Simón C, García-velasco JA, Pellicer A. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update. 2008;14:321-33.
• Gómez R, Simon C, Remohi J, Pellicer A. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology. 2002;143:4339-48.
• Rizk B, Aboulghar M, Smitz J, Ron-EI R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update. 1997;3:255-66.

Terms in the title (6)： カベルゴリン ,  投与 ,  卵巣過刺激症候群 ,  予防 ,  卵巣 ,  容積